Coronation Fund Managers Ltd. Takeda Pharmaceutical CO LTD Transaction History

Coronation Fund Managers Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$13.02 - $20.31 $419,439 - $654,286	-32,215 Closed	0 $0
Q4 2019 Jan 21, 2020	BUY	$16.88 - $20.83 $313,832 - $387,271	18,592 Added 136.48%	32,215 $636,000
Q3 2019 Nov 01, 2019	SELL	$16.15 - $17.99 $76,502 - $85,218	-4,737 Reduced 25.8%	13,623 $234,000
Q2 2019 Jul 25, 2019	BUY	$16.58 - $20.49 $304,408 - $376,196	18,360 New	18,360 $325,000

336

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.3B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Coronation Fund Managers Ltd., based on Form 13F filings with the SEC.

Stay updated on Coronation Fund Managers Ltd. with notifications on news.